News

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.
HIV/AIDS-related deaths have fallen to their lowest level in more than 40 years as a result of the fight against the virus.
Global deaths from AIDS have dropped to their lowest levels in more than 30 years, in part due to efforts to fight HIV. But U ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...
Gilead Sciences is pushing full speed ahead with its strategy to ensure global access to its long-acting HIV pre-exposure ...
Gilead will supply lenacapavir to Global Fund countries for HIV prevention, but questions remain amid PEPFAR cuts and funding ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...